Skip to main content
. 2011 May 4;6(5):e19065. doi: 10.1371/journal.pone.0019065

Figure 1. Identification of XMRV sequences in prostate cancer patients.

Figure 1

Representative nested pol PCR results using prostate tumor DNA. Lanes 1–24, prostate cancer patients, including patients 5956 (lane 8) and 6203 (lane 19); lane 25, negative human PBMC DNA control; lanes 26 and 27, water only controls for primary and nested PCR tests, respectively; lanes 28 and 29, assay sensitivity controls consisting of 10 and 103 copies of XMRV VP62 plasmid DNA diluted in a background of 1 ug of human PBMC DNA, respectively.